Laborie Medical Technologies Report issue

For profit Phase 2 Phase 4
Founded: Mississauga ON Canada (1967)
Status: No NME R&D (1967)

Organization Overview

First Clinical Trial
None
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
None

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 4 Trials (1)

Key: Laborie Medical Technologies (0) Acquired (1)

tolterodine (detrol) (1 trial)

Drugs in Phase 2 Trials (1)

Key: Laborie Medical Technologies (0) Acquired (1)

paclitaxel (taxol) (1 trial)

Indications

Overview

  • Highest Phase: None
  • # of Trials: 2
  • # of Trial APIs: 2